Introduction
Leukemia is one of the most common pediatric cancers accounting for about 30% of diagnosis (1) . There are two main subtypes; acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML) AML is less common, accounting for approximately 18% of childhood leukemia diagnosis (1) . About 20% of the cases of childhood AML are in children younger than 24 months; half of these cases occur within the first 12 months. Common presenting symptoms include fever, fatigue, pallor, bruising, petechiae, bone pain, infections not responding to appropriate antibiotic therapy (2) . Severe hypertriglyceridemia is rare and generally associated with either eruptive xanthomata or pancreatitis usually due to a primary deficiency in lipoprotein lipase (LPL) or its cofactor, apolipoprotein C-II, activity allied to other exacerbating factors, e.g. acute infection, obesity or diabetes. The association of severe hypertriglyceridemia (type IV or V hyperlipidaemia) with hematological or solid organ malignancy has only been noted to occur in rare acute cases (3) . In this report, we present hyperlipidemia in a case of AML because of rarely presentation. According to our knowledge, this is the first pediatric case with report AML associated with hyperlipidemia.
Case report
She was a 2-month-old girl complaining of discomfort. On physical examination, her skin and conjunctivae were pale, abdominal distention and 5 cm hepatosplenomegaly were determined. The main physical examination findings were unremarkable. Blood count revealed anemia (10 g/dL) and thrombocytopenia (41x10 9 /L). Total leukocyte count was 24x10 9 /L, and on blood smear, 58% blast and 42% lymphocytes were seen. Bone marrow aspirate revealed diffuse infiltration with blast cells consistent with acute monoblastic leukemia. Her plasma had a milky appearance. On the laboratory examination, triglyceride level was 1428 mg/dl (32-99 mg/dl), total cholesterol level was 1291 mg/dl (109-189 mg/dl), LDL cholesterol level was 870 mg/dl (60-150 mg/dl), HDL cholesterol level was 12 mg/dl (35-84 mg/dl), very low density lipoprotein (VLDL) cholesterol level was 286 mg/dl (0-40 mg/dl) and serum glucose level was 92 mg/dL (70-110 mg/dL). Serum amylase, pancreatic lipase, phosphor, sodium, potassium and calcium levels were normal range. Family history was negative for lipid disorders.
Discussion
The exact mechanism underlying the lipid abnormalities is not completely understood and remains to be elucidated. It has been suggested that it might be linked to an increase in endogenous hepatic synthesis of VLDL. Another suggested mechanism is decreased enzymatic activity of LPL, a key enzyme in the removal of triglyceride-rich lipoproteins from the plasma, resulting in decreased clearance and hypertriglyceridemia (4) . Severe hypertriglyceridemia (>1000 mg/dL) is a well-known side effect of induction chemotherapy in acute leukemia. This is usually secondary to combination with L-asparaginase and glucocorticoids, both of which are essential drugs in this treatment phase. Usually, hypertriglyceridemia is benign, transient and asymptomatic (5). Parsons et al. (5) reported 67% of incidence of hypertriglyceridemia and 19% with levels greater than 1000 mg/dl. Nesheli et al. was found of the 77 patients, 37 (48%) received asparaginase therapy and 40 (52%) patients did not. The mean peak triglyceride and cholesterol levels during asparaginase therapy in the first group were significantly higher than the levels in the second group (6). Tajima et al. demonstrated the synthesis of LPL has been in human monocytic leukemia cells indicating that this enzyme may play a role in tumour biology (7). Our patient had been diagnosed with AML and did not receive any chemotherapy. This case report illustrate that the hematological malignancies may present with severe hypertriglyceridemia.
